Cvi Holdings, LLC Cellectar Biosciences, Inc. Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$10.6 - $16.6 $1.48 Million - $2.32 Million	-139,979 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.3 - $17.3 $1.44 Million - $2.42 Million	139,979 New	139,979 $179,000
Q3 2019 Nov 14, 2019	SELL	$20.0 - $24.6 $2.12 Million - $2.61 Million	-106,026 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.6 - $28.2 $1.97 Million - $2.99 Million	106,026 New	106,026 $231,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $13M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.